Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Oct 14, 2011


Vermillion announced this week that Sandra Gardiner has resigned as vice president and chief financial officer and is leaving the company to take a job with an undisclosed firm in the San Francisco Bay Area.

The company also appointed Eric Schoen as chief accounting officer. Previously Schoen was corporate controller at Vermillion. Before that he was revenue controller for Borland Software.

Hybrigenics has appointed Alain Munoz to its board of directors. Munoz replaces Bernhard Ehmer, president of ImClone Systems, and will chair the company's clinical advisory board.

Munoz is a board member at several biotech companies including Vivalis, Novagali Pharma, and Zealand Pharma. Previously he was R&D vice president at the Sanofi Group and senior vice president of the pharmaceutical division at Fournier.

Riccardo Pigliucci has joined Bioscale's board of directors.

Pigliucci is the former chief operating operator of PerkinElmer as well as CEO of Life Sciences International and Discovery Partners International. He was also lead director on the board of Dionex, which was recently purchased by Thermo Fisher Scientific.

Protea Biosciences has hired Alessandro Baldi as vice president and general manager.

Previously Baldi was senior director of PerkinElmer's mass spectrometry business.